cis-retinoic acid
Small moleculeexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Aug 31, 2021 (NCT05016349)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06020833 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2023 | Chinese Academy of Medical Sciences |
| NCT05384821 | Phase 1/Phase 2 (Phase 2) | May 31, 2022 | CHU La Timone, University of Lille |
| NCT05077813 | Phase 2 | Dec 31, 2021 | Damietta University, Government of Saudi Arabia, Kafrelsheikh University |
| NCT05016349 | Phase 3 | Aug 31, 2021 | Damitta University, Government of Saudi Arabia, Kafrelsheikh University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Saudi Arabia | Government | 2 | 1 | 2 | 2021 |
| Kafrelsheikh University | Academic/Hospital | 2 | 1 | 2 | 2021 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2023 |
| CHU La Timone | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Damietta University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Damitta University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of Lille | Academic/Hospital | 1 | 1 | 1 | 2022 |
7 organizations
Page 1 / 1